Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

TAP Prevacid Consumer Campaign Will Include Nexium Comparison

Executive Summary

TAP's Prevacid consumer promotions will include study data comparing the product to AstraZeneca's Nexium (esomeprazole) that will be published by the end of March

You may also be interested in...



Abbott Will Outlicense Ketolide Antibiotic, Focus On Quinolone And D2E7

Abbott is seeking to outlicense its ketolide antibiotic ABT-773 in lieu of expanding Phase III development to address class issues

Abbott Will Outlicense Ketolide Antibiotic, Focus On Quinolone And D2E7

Abbott is seeking to outlicense its ketolide antibiotic ABT-773 in lieu of expanding Phase III development to address class issues

Protonix, Nexium Growing Share, Wyeth Says; No Prilosec Generic In '01

Wyeth-Ayerst's Protonix and AstraZeneca's Nexium are the only proton pump inhibitors growing market share, Wyeth Pharmaceuticals President Bernard Poussot said during an Oct. 23 conference call.

UsernamePublicRestriction

Register

MT142464

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel